DUDLEY ROBERT MICHAEL enters TRANSCODE THERAPEUTICS, INC. with 843.11K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/8/2021ACC: 0001104659-21-090405
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2021
843.11K
Baseline shares
100% direct
843.11K
Direct ownership
1 position
818.85K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned843.11K
Total
843.11K direct843.11K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 843.11K | Direct |
| Total | 843.11K | 843.11K direct |
Derivative Holdings1
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
818.85K
Shares owned
N/A
Exercise price
0.091
Expiration
—
Exercise window
—
Total
Underlying
818.85K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 0.091 | — | — | 818.85K | N/A |
| Total | 818.85K | 0.00 | ||||